{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T21:13:27Z","timestamp":1789766007525,"version":"4.0.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T00:00:00Z","timestamp":1683849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR002490"],"award-info":[{"award-number":["KL2TR002490"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Allergy Asthma Rep"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s11882-023-01083-0","type":"journal-article","created":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T10:04:07Z","timestamp":1683885847000},"page":"341-350","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Multisystem Inflammatory Syndrome in Children and Kawasaki Disease: Parallels in Pathogenesis and Treatment"],"prefix":"10.1007","volume":"23","author":[{"given":"Laura","family":"Cannon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jay","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-6843","authenticated-orcid":false,"given":"Eveline Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,12]]},"reference":[{"issue":"5","key":"1083_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/1756-185x.12408","volume":"17","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T. Kawasaki disease. Int J Rheum Dis. 2014;17(5):597\u2013600. https:\/\/doi.org\/10.1111\/1756-185x.12408.","journal-title":"Int J Rheum Dis"},{"issue":"10237","key":"1083_CR2","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1016\/s0140-6736(20)31094-1","volume":"395","author":"S Riphagen","year":"2020","unstructured":"Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(20)31094-1.","journal-title":"Lancet"},{"key":"1083_CR3","doi-asserted-by":"publisher","unstructured":"Cucinotta D, Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91(1):157\u201360. https:\/\/doi.org\/10.23750\/abm.v91i1.9397.","DOI":"10.23750\/abm.v91i1.9397"},{"key":"1083_CR4","doi-asserted-by":"publisher","unstructured":"Lo MS. A framework for understanding Kawasaki disease pathogenesis. Clin Immunol. 2020;214:108385. https:\/\/doi.org\/10.1016\/j.clim.2020.108385.","DOI":"10.1016\/j.clim.2020.108385"},{"issue":"1","key":"1083_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ng.2007.59","volume":"40","author":"Y Onouchi","year":"2008","unstructured":"Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40(1):35\u201342. https:\/\/doi.org\/10.1038\/ng.2007.59.","journal-title":"Nat Genet"},{"issue":"5","key":"1083_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/art.40784","volume":"71","author":"G Armaroli","year":"2019","unstructured":"Armaroli G, Verweyen E, Pretzer C, Kessel K, Hirono K, Ichida F, et al. Monocyte-derived interleukin-1\u03b2 as the driver of S100A12-induced sterile inflammatory activation of human coronary artery endothelial cells: implications for the pathogenesis of Kawasaki disease. Arthritis Rheumatol. 2019;71(5):792\u2013804. https:\/\/doi.org\/10.1002\/art.40784.","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1083_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2249.2010.04236.x","volume":"162","author":"S Jia","year":"2010","unstructured":"Jia S, Li C, Wang G, Yang J, Zu Y. The T helper type 17\/regulatory T cell imbalance in patients with acute Kawasaki disease. Clin Exp Immunol. 2010;162(1):131\u20137. https:\/\/doi.org\/10.1111\/j.1365-2249.2010.04236.x.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1083_CR8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/art.39939","volume":"69","author":"M Noval Rivas","year":"2017","unstructured":"Noval Rivas M, Lee Y, Wakita D, Chiba N, Dagvadorj J, Shimada K, et al. CD8+ T cells contribute to the development of coronary arteritis in the Lactobacillus casei cell wall extract-induced murine model of Kawasaki disease. Arthritis Rheumatol. 2017;69(2):410\u201321. https:\/\/doi.org\/10.1002\/art.39939.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"1083_CR9","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1097\/BOR.0b013e32833cf051","volume":"22","author":"RS Yeung","year":"2010","unstructured":"Yeung RS. Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol. 2010;22(5):551\u201360. https:\/\/doi.org\/10.1097\/BOR.0b013e32833cf051.","journal-title":"Curr Opin Rheumatol"},{"key":"1083_CR10","unstructured":"Doi M, Takeda T, Sakurai Y, Kato J, Hayashi T, Fukuda K, et al. Altered immunoglobulin A and M levels associated with changes in BAFF and APRIL after administration of intravenous immunoglobulin to treat Kawasaki disease. J Investig Allergol Clin Immunol. 2010;20(5):413\u20138."},{"issue":"12","key":"1083_CR11","doi-asserted-by":"publisher","first-page":"5946","DOI":"10.4049\/jimmunol.159.12.5946","volume":"159","author":"AH Rowley","year":"1997","unstructured":"Rowley AH, Eckerley CA, J\u00e4ck HM, Shulman ST, Baker SC. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. J Immunol. 1997;159(12):5946\u201355.","journal-title":"J Immunol"},{"issue":"3","key":"1083_CR12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.immuni.2019.05.021","volume":"51","author":"M Noval Rivas","year":"2019","unstructured":"Noval Rivas M, Wakita D, Franklin MK, Carvalho TT, Abolhesn A, Gomez AC, et al. Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation. Immunity. 2019;51(3):508-21.e6. https:\/\/doi.org\/10.1016\/j.immuni.2019.05.021.","journal-title":"Immunity"},{"issue":"2","key":"1083_CR13","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/cdli.10.2.308-314.2003","volume":"10","author":"PK Chua","year":"2003","unstructured":"Chua PK, Melish ME, Yu Q, Yanagihara R, Yamamoto KS, Nerurkar VR. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin Diagn Lab Immunol. 2003;10(2):308\u201314. https:\/\/doi.org\/10.1128\/cdli.10.2.308-314.2003.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1","key":"1083_CR14","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s10020-022-00583-5","volume":"28","author":"CB Santos-Rebou\u00e7as","year":"2022","unstructured":"Santos-Rebou\u00e7as CB, Piergiorge RM, Dos Santos FC, SeixasZeitel R, Gerber AL, Rodrigues MCF, et al. Host genetic susceptibility underlying SARS-CoV-2-associated multisystem inflammatory syndrome in Brazilian children. Mol Med. 2022;28(1):153. https:\/\/doi.org\/10.1186\/s10020-022-00583-5.","journal-title":"Mol Med"},{"issue":"5","key":"1083_CR15","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jaci.2022.09.005","volume":"150","author":"H Abolhassani","year":"2022","unstructured":"Abolhassani H, Delavari S, Landegren N, Shokri S, Bastard P, Du L, et al. Genetic and immunologic evaluation of children with inborn errors of immunity and severe or critical COVID-19. J Allergy Clin Immunol. 2022;150(5):1059\u201373. https:\/\/doi.org\/10.1016\/j.jaci.2022.09.005.","journal-title":"J Allergy Clin Immunol"},{"key":"1083_CR16","doi-asserted-by":"publisher","unstructured":"\u2022 Chou J, Platt CD, Habiballah S, Nguyen AA, Elkins M, Weeks S, et al. Mechanisms underlying genetic susceptibility to multisystem inflammatory syndrome in children (MIS-C). J Allergy Clin Immunol. 2021;148(3):732\u20138.e1. https:\/\/doi.org\/10.1016\/j.jaci.2021.06.024. A single-center cohort study demonstrating MIS-C patients were enriched for monogenic susceptibility to inflammation.","DOI":"10.1016\/j.jaci.2021.06.024"},{"issue":"5","key":"1083_CR17","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.jaci.2020.07.033","volume":"146","author":"PY Lee","year":"2020","unstructured":"Lee PY, Platt CD, Weeks S, Grace RF, Maher G, Gauthier K, et al. Immune dysregulation and multisystem inflammatory syndrome in children (MIS-C) in individuals with haploinsufficiency of SOCS1. J Allergy Clin Immunol. 2020;146(5):1194-200.e1. https:\/\/doi.org\/10.1016\/j.jaci.2020.07.033.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"1083_CR18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1038\/s41591-020-1054-6","volume":"26","author":"MJ Carter","year":"2020","unstructured":"Carter MJ, Fish M, Jennings A, Doores KJ, Wellman P, Seow J, et al. Peripheral immunophenotypes in children with multisystem inflammatory syndrome associated with SARS-CoV-2 infection. Nat Med. 2020;26(11):1701\u20137. https:\/\/doi.org\/10.1038\/s41591-020-1054-6.","journal-title":"Nat Med"},{"issue":"11","key":"1083_CR19","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1172\/jci140970","volume":"130","author":"C Diorio","year":"2020","unstructured":"Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. J Clin Invest. 2020;130(11):5967\u201375. https:\/\/doi.org\/10.1172\/jci140970.","journal-title":"J Clin Invest"},{"issue":"23","key":"1083_CR20","doi-asserted-by":"publisher","first-page":"6051","DOI":"10.1182\/bloodadvances.2020003471","volume":"4","author":"C Diorio","year":"2020","unstructured":"Diorio C, McNerney KO, Lambert M, Paessler M, Anderson EM, Henrickson SE, et al. Evidence of thrombotic microangiopathy in children with SARS-CoV-2 across the spectrum of clinical presentations. Blood Adv. 2020;4(23):6051\u201363. https:\/\/doi.org\/10.1182\/bloodadvances.2020003471.","journal-title":"Blood Adv"},{"issue":"4","key":"1083_CR21","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","volume":"183","author":"CN Gruber","year":"2020","unstructured":"Gruber CN, Patel RS, Trachtman R, Lepow L, Amanat F, Krammer F, et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2020;183(4):982-95.e14. https:\/\/doi.org\/10.1016\/j.cell.2020.09.034.","journal-title":"Cell"},{"issue":"12","key":"1083_CR22","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41584-021-00709-9","volume":"17","author":"C Sharma","year":"2021","unstructured":"Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. 2021;17(12):731\u201348. https:\/\/doi.org\/10.1038\/s41584-021-00709-9.","journal-title":"Nat Rev Rheumatol"},{"key":"1083_CR23","doi-asserted-by":"publisher","unstructured":"Vella LA, Giles JR, Baxter AE, Oldridge DA, Diorio C, Kuri-Cervantes L, et al. Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared to adult and pediatric COVID-19. Sci Immunol. 2021;6(57). https:\/\/doi.org\/10.1126\/sciimmunol.abf7570.","DOI":"10.1126\/sciimmunol.abf7570"},{"issue":"4","key":"1083_CR24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","volume":"183","author":"CR Consiglio","year":"2020","unstructured":"Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020;183(4):968-81.e7. https:\/\/doi.org\/10.1016\/j.cell.2020.09.016.","journal-title":"Cell"},{"key":"1083_CR25","doi-asserted-by":"publisher","unstructured":"\u2022 Esteve-Sole A, Anton J, Pino-Ramirez RM, Sanchez-Manubens J, Fumad\u00f3 V, Fortuny C, et al. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease. J Clin Invest. 2021;131(6). https:\/\/doi.org\/10.1172\/jci144554. The study performed cytokine profiling in pediatric patients with MIS-C and pre-pandemic KD, and results suggest IFN-\u03b3 and inflammatory monocytes are important drivers of inflammation in MIS-C.","DOI":"10.1172\/jci144554"},{"issue":"6","key":"1083_CR26","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/INF.0b013e3181cf8705","volume":"29","author":"RC Holman","year":"2010","unstructured":"Holman RC, Belay ED, Christensen KY, Folkema AM, Steiner CA, Schonberger LB. Hospitalizations for Kawasaki syndrome among children in the United States, 1997\u20132007. Pediatr Infect Dis J. 2010;29(6):483\u20138. https:\/\/doi.org\/10.1097\/INF.0b013e3181cf8705.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"1083_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1542\/peds.2008-0730","volume":"124","author":"MB Son","year":"2009","unstructured":"Son MB, Gauvreau K, Ma L, Baker AL, Sundel RP, Fulton DR, et al. Treatment of Kawasaki disease: analysis of 27 US pediatric hospitals from 2001 to 2006. Pediatrics. 2009;124(1):1\u20138. https:\/\/doi.org\/10.1542\/peds.2008-0730.","journal-title":"Pediatrics"},{"key":"1083_CR28","doi-asserted-by":"publisher","unstructured":"Sundel RP. Kawasaki disease. Rheum Dis Clin North Am. 2015;41(1):63\u201373, viii. https:\/\/doi.org\/10.1016\/j.rdc.2014.09.010.","DOI":"10.1016\/j.rdc.2014.09.010"},{"key":"1083_CR29","doi-asserted-by":"publisher","unstructured":"\u2022 Son MBF, Gauvreau K, Tremoulet AH, Lo M, Baker AL, de Ferranti S, et al. Risk model development and validation for prediction of coronary artery aneurysms in Kawasaki disease in a North American population. J Am Heart Assoc. 2019;8(11):e011319. https:\/\/doi.org\/10.1161\/jaha.118.011319. This study aims to develop a risk model predictive of coronary artery aneurysm development, a major determinant of Kawasaki disease morbidity, for North American cohorts.","DOI":"10.1161\/jaha.118.011319"},{"key":"1083_CR30","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jpeds.2017.03.025","volume":"185","author":"AP Salgado","year":"2017","unstructured":"Salgado AP, Ashouri N, Berry EK, Sun X, Jain S, Burns JC, et al. High Risk of Coronary Artery Aneurysms in Infants Younger than 6 Months of Age with Kawasaki Disease. J Pediatr. 2017;185:112-6.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2017.03.025.","journal-title":"J Pediatr"},{"issue":"3","key":"1083_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00431-012-1879-1","volume":"172","author":"LB G\u00e1mez-Gonz\u00e1lez","year":"2013","unstructured":"G\u00e1mez-Gonz\u00e1lez LB, Murata C, Mu\u00f1oz-Ram\u00edrez M, Yamazaki-Nakashimada M. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr. 2013;172(3):337\u201342. https:\/\/doi.org\/10.1007\/s00431-012-1879-1.","journal-title":"Eur J Pediatr"},{"issue":"4","key":"1083_CR32","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1056\/NEJMoa2021756","volume":"383","author":"EM Dufort","year":"2020","unstructured":"Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020;383(4):347\u201358. https:\/\/doi.org\/10.1056\/NEJMoa2021756.","journal-title":"N Engl J Med"},{"key":"1083_CR33","doi-asserted-by":"publisher","unstructured":"Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med. 2020;383(4):334\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2021680.","DOI":"10.1056\/NEJMoa2021680"},{"issue":"3","key":"1083_CR34","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1001\/jama.2020.10369","volume":"324","author":"E Whittaker","year":"2020","unstructured":"Whittaker E, Bamford A, Kenny J, Kaforou M, Jones CE, Shah P, et al. Clinical characteristics of 58 children with a pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. JAMA. 2020;324(3):259\u201369. https:\/\/doi.org\/10.1001\/jama.2020.10369.","journal-title":"JAMA"},{"key":"1083_CR35","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325(11):1074\u201387. https:\/\/doi.org\/10.1001\/jama.2021.2091. This report is one of the largest case series including 539 children with MIS-C from the Overcoming COVID-19 surveillance registry. The study observed that most cardiovascular involvement resolved over time.","DOI":"10.1001\/jama.2021.2091"},{"issue":"3","key":"1083_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/MOP.0b013e3280dd8c4a","volume":"19","author":"SC Susarla","year":"2007","unstructured":"Susarla SC, Fan LL. Diffuse alveolar hemorrhage syndromes in children. Curr Opin Pediatr. 2007;19(3):314\u201320. https:\/\/doi.org\/10.1097\/MOP.0b013e3280dd8c4a.","journal-title":"Curr Opin Pediatr"},{"key":"1083_CR37","doi-asserted-by":"publisher","unstructured":"Son MBF, Burns JC, Newburger JW. A new definition for multisystem inflammatory syndrome in children. Pediatr. 2023. https:\/\/doi.org\/10.1542\/peds.2022-060302.","DOI":"10.1542\/peds.2022-060302"},{"issue":"4","key":"1083_CR38","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1053\/j.gastro.2020.05.079","volume":"159","author":"J Miller","year":"2020","unstructured":"Miller J, Cantor A, Zachariah P, Ahn D, Martinez M, Margolis KG. Gastrointestinal symptoms as a major presentation component of a novel multisystem inflammatory syndrome in children that is related to Coronavirus disease 2019: a single center experience of 44 cases. Gastroenterology. 2020;159(4):1571-4.e2. https:\/\/doi.org\/10.1053\/j.gastro.2020.05.079.","journal-title":"Gastroenterology"},{"issue":"4","key":"1083_CR39","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.jpeds.2008.10.006","volume":"154","author":"AL Baker","year":"2009","unstructured":"Baker AL, Lu M, Minich LL, Atz AM, Klein GL, Korsin R, et al. Associated symptoms in the ten days before diagnosis of Kawasaki disease. J Pediatr. 2009;154(4):592-5.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2008.10.006.","journal-title":"J Pediatr"},{"issue":"17","key":"1083_CR40","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/cir.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927\u201399. https:\/\/doi.org\/10.1161\/cir.0000000000000484.","journal-title":"Circulation"},{"issue":"11","key":"1083_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11886-021-01602-3","volume":"23","author":"EY Wu","year":"2021","unstructured":"Wu EY, Campbell MJ. Cardiac Manifestations of multisystem inflammatory syndrome in children (MIS-C) following COVID-19. Curr Cardiol Rep. 2021;23(11):168. https:\/\/doi.org\/10.1007\/s11886-021-01602-3.","journal-title":"Curr Cardiol Rep"},{"key":"1083_CR42","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Son MBF, Murray N, Friedman K, Young CC, Newhams MM, Feldstein LR, et al. Multisystem inflammatory syndrome in children - initial therapy and outcomes. N Engl J Med. 2021;385(1):23\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2102605. This study looked at 518 MIS-C patients from the Overcoming COVID-19 surveillance registry and found that initial treatment with IVIG plus corticosteroids was associated with lower risk of cardiovascular dysfunction than IVIG alone.","DOI":"10.1056\/NEJMoa2102605"},{"key":"1083_CR43","doi-asserted-by":"publisher","unstructured":"Wardle AJ, Connolly GM, Seager MJ, Tulloh RM. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2017;1(1):Cd011188. https:\/\/doi.org\/10.1002\/14651858.CD011188.pub2.","DOI":"10.1002\/14651858.CD011188.pub2"},{"key":"1083_CR44","doi-asserted-by":"publisher","unstructured":"Son MBF, Gauvreau K, Kim S, Tang A, Dedeoglu F, Fulton DR, et al. Predicting coronary artery aneurysms in Kawasaki disease at a North American Center: an assessment of baseline z scores. J Am Heart Assoc. 2017;6(6). https:\/\/doi.org\/10.1161\/jaha.116.005378.","DOI":"10.1161\/jaha.116.005378"},{"key":"1083_CR45","doi-asserted-by":"publisher","unstructured":"\u2022 de Graeff N, Groot N, Ozen S, Eleftheriou D, Avcin T, Bader-Meunier B, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. Rheumatology (Oxford). 2019;58(4):672\u201382. https:\/\/doi.org\/10.1093\/rheumatology\/key344. This report provides international evidence-based recommendations for diagnosing and treated KD in children to facilitate uniformity in care.","DOI":"10.1093\/rheumatology\/key344"},{"issue":"9826","key":"1083_CR46","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/s0140-6736(11)61930-2","volume":"379","author":"T Kobayashi","year":"2012","unstructured":"Kobayashi T, Saji T, Otani T, Takeuchi K, Nakamura T, Arakawa H, et al. Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial. Lancet. 2012;379(9826):1613\u201320. https:\/\/doi.org\/10.1016\/s0140-6736(11)61930-2.","journal-title":"Lancet"},{"issue":"9930","key":"1083_CR47","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/s0140-6736(13)62298-9","volume":"383","author":"AH Tremoulet","year":"2014","unstructured":"Tremoulet AH, Jain S, Jaggi P, Jimenez-Fernandez S, Pancheri JM, Sun X, et al. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9930):1731\u20138. https:\/\/doi.org\/10.1016\/s0140-6736(13)62298-9.","journal-title":"Lancet"},{"issue":"12","key":"1083_CR48","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/s2352-4642(21)00270-4","volume":"5","author":"JC Burns","year":"2021","unstructured":"Burns JC, Roberts SC, Tremoulet AH, He F, Printz BF, Ashouri N, et al. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial. Lancet Child Adolesc Health. 2021;5(12):852\u201361. https:\/\/doi.org\/10.1016\/s2352-4642(21)00270-4.","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"1083_CR49","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1002\/art.41454","volume":"72","author":"LA Henderson","year":"2020","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020;72(11):1791\u2013805. https:\/\/doi.org\/10.1002\/art.41454.","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"1083_CR50","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1002\/art.41616","volume":"73","author":"LA Henderson","year":"2021","unstructured":"Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 2. Arthritis Rheumatol. 2021;73(4):e13\u201329. https:\/\/doi.org\/10.1002\/art.41616.","journal-title":"Arthritis Rheumatol"},{"key":"1083_CR51","doi-asserted-by":"publisher","unstructured":"\u2022\u2022 Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 3. Arthritis Rheumatol. 2022;74(4):e1-e20. https:\/\/doi.org\/10.1002\/art.42062. The most recent version of clinical guidance recommendations for MIS-C endorsed by the American College of Rheumatology.","DOI":"10.1002\/art.42062"},{"issue":"1","key":"1083_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa2102968","volume":"385","author":"AJ McArdle","year":"2021","unstructured":"McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, et al. Treatment of multisystem inflammatory syndrome in children. N Engl J Med. 2021;385(1):11\u201322. https:\/\/doi.org\/10.1056\/NEJMoa2102968.","journal-title":"N Engl J Med"},{"issue":"2","key":"1083_CR53","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1182\/blood.2020010218","volume":"138","author":"H Whitworth","year":"2021","unstructured":"Whitworth H, Sartain SE, Kumar R, Armstrong K, Ballester L, Betensky M, et al. Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C. Blood. 2021;138(2):190\u20138. https:\/\/doi.org\/10.1182\/blood.2020010218.","journal-title":"Blood"},{"key":"1083_CR54","doi-asserted-by":"publisher","unstructured":"Zambrano LD, Newhams MM, Olson SM, Halasa NB, Price AM, Boom JA, et al. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA vaccination against multisystem inflammatory syndrome in children among persons aged 12\u201318 years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022;71(2):52\u20138. https:\/\/doi.org\/10.15585\/mmwr.mm7102e1.","DOI":"10.15585\/mmwr.mm7102e1"},{"issue":"15","key":"1083_CR55","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/circulationaha.106.183095","volume":"116","author":"W Wilson","year":"2007","unstructured":"Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116(15):1736\u201354. https:\/\/doi.org\/10.1161\/circulationaha.106.183095.","journal-title":"Circulation"},{"issue":"25","key":"1083_CR56","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1161\/circulationaha.107.749515","volume":"118","author":"H Senzaki","year":"2008","unstructured":"Senzaki H. Long-term outcome of Kawasaki disease. Circulation. 2008;118(25):2763\u201372. https:\/\/doi.org\/10.1161\/circulationaha.107.749515.","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"1083_CR57","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/s0022-3476(05)81894-3","volume":"121","author":"T Akagi","year":"1992","unstructured":"Akagi T, Rose V, Benson LN, Newman A, Freedom RM. Outcome of coronary artery aneurysms after Kawasaki disease. J Pediatr. 1992;121(5 Pt 1):689\u201394. https:\/\/doi.org\/10.1016\/s0022-3476(05)81894-3.","journal-title":"J Pediatr"},{"issue":"1","key":"1083_CR58","doi-asserted-by":"publisher","first-page":"e1165","DOI":"10.1093\/cid\/ciab1007","volume":"75","author":"AD Miller","year":"2022","unstructured":"Miller AD, Zambrano LD, Yousaf AR, Abrams JY, Meng L, Wu MJ, et al. Multisystem inflammatory syndrome in children-United States, February 2020-July 2021. Clin Infect Dis. 2022;75(1):e1165\u201375. https:\/\/doi.org\/10.1093\/cid\/ciab1007.","journal-title":"Clin Infect Dis"},{"key":"1083_CR59","doi-asserted-by":"publisher","unstructured":"Capone CA, Misra N, Ganigara M, Epstein S, Rajan S, Acharya SS, et al. Six month follow-up of patients with multi-system inflammatory syndrome in children. Pediatr. 2021;148(4). https:\/\/doi.org\/10.1542\/peds.2021-050973.","DOI":"10.1542\/peds.2021-050973"},{"issue":"8","key":"1083_CR60","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1007\/s00246-022-02927-8","volume":"43","author":"A Chakraborty","year":"2022","unstructured":"Chakraborty A, Philip R, Santoso M, Naik R, Merlocco A, Johnson JN. Cardiovascular magnetic resonance in children with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: institutional protocol-based medium-term follow-up study. Pediatr Cardiol. 2022;43(8):1879\u201387. https:\/\/doi.org\/10.1007\/s00246-022-02927-8.","journal-title":"Pediatr Cardiol"},{"key":"1083_CR61","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jpeds.2021.10.009","volume":"241","author":"DM Barris","year":"2022","unstructured":"Barris DM, Keelan J, Ahluwalia N, Jhaveri S, Cohen J, Stern K, et al. Midterm outcomes and cardiac magnetic resonance imaging following multisystem inflammatory syndrome in children. J Pediatr. 2022;241:237-41.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2021.10.009.","journal-title":"J Pediatr"},{"key":"1083_CR62","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ahj.2021.08.003","volume":"243","author":"DT Truong","year":"2022","unstructured":"Truong DT, Trachtenberg FL, Pearson GD, Dionne A, Elias MD, Friedman K, et al. The NHLBI study on long-term outcomes after the multisystem inflammatory syndrome in children (MUSIC): design and objectives. Am Heart J. 2022;243:43\u201353. https:\/\/doi.org\/10.1016\/j.ahj.2021.08.003.","journal-title":"Am Heart J"}],"container-title":["Current Allergy and Asthma Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-023-01083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11882-023-01083-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11882-023-01083-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T01:01:15Z","timestamp":1744160475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11882-023-01083-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,12]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1083"],"URL":"https:\/\/doi.org\/10.1007\/s11882-023-01083-0","relation":{},"ISSN":["1529-7322","1534-6315"],"issn-type":[{"value":"1529-7322","type":"print"},{"value":"1534-6315","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,12]]},"assertion":[{"value":"21 April 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Cannon declares that she has no conflict of interest. Dr. Campbell reports personal fees from Longeveron Inc. and grants from the CDC Clinical Immunization Safety Assessment, outside the submitted work. Dr. Wu reports Advisory Board fees and Speaker honorarium from Pharming Healthcare, Inc. and Advisory Board fees from Enzyvant Therapeutics, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}